(Q35807418)

10 August 2017

Extracting β-amyloid from Alzheimer's disease (English)

1 reference

10 August 2017

0 references

Daniel R Dries

1

1 reference

10 August 2017

Gang Yu

series ordinal

2

1 reference

10 August 2017

Joachim Herz

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

10 February 2012

1 reference

Proceedings of the National Academy of Sciences of the United States of America

10 August 2017

1 reference

10 August 2017

109

1 reference

10 August 2017

9

1 reference

10 August 2017

3199-3200

1 reference

Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Resolving controversies on the path to Alzheimer's therapeutics

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Modified immunotherapies against Alzheimer's disease: toward safer and effective amyloid clearance

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Lipoprotein receptors – an evolutionarily ancient multifunctional receptor family

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Can Alzheimer disease be prevented by amyloid-beta immunotherapy?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

The secretases: enzymes with therapeutic potential in Alzheimer disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Assembly, maturation, and trafficking of the gamma-secretase complex in Alzheimer's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Clearance of amyloid-beta by circulating lipoprotein receptors

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Neuritic regeneration and synaptic reconstruction induced by withanolide A

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295249

Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration

11 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1121560109

Will anti-amyloid therapies work for Alzheimer's disease?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1121560109

Modified Immunotherapies Against Alzheimer's Disease: Toward Safer and Effective Amyloid-β Clearance

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1121560109

21 January 2018

Identifiers

DOI

10.1073/PNAS.1121560109

1 reference

10 August 2017

0 references

1 reference

10 August 2017

PubMed publication ID

22328154

1 reference